EUVIMEDEUVIMED entdecken
Crossref

Surgical outcome in patients with lung adenocarcinoma with mucin

Keiko Ueda, Yo Kawaguchi, Yasushi Itoh, Daigo Ishihara, Hiroki Saito, Takuya Shiratori, Keigo Okamoto, Yoko Kataoka, Mayumi Ohshio, Yasuhiko Ohshio, Jun Hanaoka

General Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1007/s11748-024-02103-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift General Thoracic and Cardiovascular Surgery, 2025. Verfasst von Keiko Ueda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Tsukinowacho, Seta, Otsu, Shiga, 520-2192, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Pneumonectomy, Mucins. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Mucin-producing adenocarcinoma is a less common variant of lung adenocarcinoma. Adenocarcinoma cells with mucin can spread through the airspace via mucus-mediated extension, leading to their implantation in distant normal lungs. Consequently, post-operative intrapulmonary recurrence frequently occurs. Mucin-producing adenocarcinomas include not only invasive mucinous adenocarcinoma but also papillary, acinar, and other subtypes. Despite increasing reports on surgical outcomes for invasive mucinous adenocarcinomas, the outcomes for total mucin-producing adenocarcinoma remain unclear. METHODS: We clinically and pathologically evaluated 511 patients who underwent curative resection for lung adenocarcinoma at our institution. The patients were divided into adenocarcinoma with mucin and without mucin groups. Based on pathological findings, the adenocarcinoma with mucin was further classified into intracellular, extracellular, and mucus extension types. Additionally, the CT value of the tumor mass was analyzed using SYNAPSE VINCENT software. RESULTS: The 5 year overall survival after surgery was 81.5% and 75.9% for patients with adenocarcinoma with versus without mucin (P = 0.774), respectively. The 5 year intrapulmonary recurrence rate in patients with adenocarcinoma with mucin was 29.2%, significantly higher than 12.9% for patients without mucin. Mucus extension was a strong indicator (hazard ratio: 3.03) of intrapulmonary recurrence after surgery. According to SYNAPSE VINCENT analysis, a high volume rate of - 400 HU indicated mucus extension. CONCLUSION: Our results demonstrated that intrapulmonary recurrence occurs approximately 2.3 times more often in adenocarcinoma with mucin than in adenocarcinoma without mucin. Mucus extension is a significant risk factor for intrapulmonary recurrence, and surgeons can predict it using SYNAPSE VINCENT analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungPneumonectomyMucinsAdenocarcinoma, MucinousHumansMaleFemaleMiddle AgedAgedTreatment OutcomeNeoplasm Recurrence, LocalRetrospective StudiesRisk FactorsTime FactorsAged, 80 and overAdult

Stichwörter der Autor:innen

Lung cancerMucinous adenocarcinomaRecurrenceSurgery

Substanzen

Mucins

Autor:innen und Institutionen

  • Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Tsukinowacho, Seta, Otsu, Shiga, 520-2192, Japan.
  • Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Tsukinowacho, Seta, Otsu, Shiga, 520-2192, Japan. kawaguchi1228@yahoo.co.jp.
  • Department of Pathology, Shiga University of Medical Science, Shiga, Japan.
  • National Hospital Organization Minami Kyoto Hospital, Kyoto, Japan.

Zitieren

APA

Ueda, K., Kawaguchi, Y., Itoh, Y., Ishihara, D., Saito, H., Shiratori, T., Okamoto, K., Kataoka, Y., Ohshio, M., Ohshio, Y., & Hanaoka, J. (2025). Surgical outcome in patients with lung adenocarcinoma with mucin. General Thoracic and Cardiovascular Surgery. https://doi.org/10.1007/s11748-024-02103-0

Vancouver

Ueda K, Kawaguchi Y, Itoh Y, Ishihara D, Saito H, Shiratori T, et al. Surgical outcome in patients with lung adenocarcinoma with mucin. General Thoracic and Cardiovascular Surgery. 2025. doi:10.1007/s11748-024-02103-0

BibTeX
@article{Ueda2025,
  author = {Ueda, Keiko and Kawaguchi, Yo and Itoh, Yasushi and Ishihara, Daigo and Saito, Hiroki and Shiratori, Takuya and Okamoto, Keigo and Kataoka, Yoko and Ohshio, Mayumi and Ohshio, Yasuhiko and Hanaoka, Jun},
  title = {Surgical outcome in patients with lung adenocarcinoma with mucin},
  journal = {General Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1007/s11748-024-02103-0}
}
Kostenlos starten →